Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.

AIDS research and human retroviruses - 20 Jan 2000

Lopalco L, Pastori C, Cosma A, Burastero S E, Capiluppi B, Boeri E, Beretta A, Lazzarin A, Siccardi A G

Abstract excerpt

Despite repeated exposures to HIV-1, some individuals remain seronegative. This study reports that sera from a fraction of exposed seronegative (ESN) subjects showed HIV-neutralizing activity; 5 of 17 ESN sera and none of 17 controls neutralized two different HIV-1 primary isolates (range of neut...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to CD4 Antigens
Share to HIV Antibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA Antigens

Share to Immunoglobulin G

Share to Precipitin Tests

Share to Receptors, CCR5

Share to Seroepidemiologic Studies

Source

Identifiers

PMID: 10659050
DOI: 10.1089/088922200309458

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-10659050-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.PMID 10659050Read ↗

CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In VitroSemantic proximity Read ↗

Differences in HIV-Specific T Cell Responses between HIV-Exposed and -Unexposed HIV-Seronegative IndividualsSemantic proximity Read ↗

Heterogeneity in exposed uninfected individuals.Semantic proximity Read ↗

Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody ResponsesSemantic proximity Read ↗

Neutralizing Antibodies Have Limited Effects on the Control of Established HIV-1 Infection In VivoSemantic proximity Read ↗

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.Semantic proximity Read ↗

Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected SubjectsSemantic proximity Read ↗

An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.Semantic proximity Read ↗

Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection.Semantic proximity Read ↗

Characterization of high-risk HIV-1 seronegative hemophiliacs.Semantic proximity Read ↗

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.Semantic proximity Read ↗

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.